Skip to Navigation


  • Email this page

Raptiva is a plaque psoriasis drug that has been linked to several life-threatening infections, including bacterial sepsis, viral meningitis, invasive fungal disease and progressive multifocal leukoencephalopathy (PML), a rare brain infection.

An injectable immunosuppressant, Raptiva leaves users susceptible to bacterial infection by stifling the immune system. Some of these infections are life threatening and require extensive medical attention and long periods of rest, which can interfere with patients' careers as well as their personal lives.

Victims of Raptiva's side effects are often entitled to receive compensation to offset medical bills, lost income and emotional distress. When a victim dies because of Raptiva, his or her immediate family members and/or heirs can file a wrongful death lawsuit.

Compensation for Raptiva Side Effects

By filing a personal injury lawsuit, Raptiva victims may be able to receive compensation for factors such as medical bills, lost opportunities, lost income, and pain and suffering. Some victims may receive additional compensation in the form of punitive damages.

Progressive Multifocal Leukoencephalopathy (PML)

Progressive multifocal leukoencephalopathy (PML) is a rare brain disease that typically occurs in patients with acquired immune deficiency syndrome (AIDS) and others undergoing immunosuppressive treatments. It is a viral infection that causes inflammation in the white matter of the brain, and often results in death.

In the event a victim dies of a defective drug death, family members can file a survivor claim as a continuation of the victim's personal injury claim. A successful survival claim may lead to compensation for medical and funeral bills, lost future income and other expenses caused by the death. Family members and heirs may receive additional compensation by filing a wrongful death claim.


Raptiva Lawsuit

Raptiva is an injectable immunosuppressant medication that is intended to treat plaque psoriasis — a chronic skin disorder. Several reports have linked Raptiva to a rare brain infection, PML, as well as other potentially deadly infections, including bacterial sepsis, viral meningitis and invasive fungal disease. Patients who develop PML after taking Raptiva may experience weakness, loss of coordination, difficulty speaking and changes in personality and vision.

In response to the reports, the Food and Drug Administration (FDA) has issued a public health advisory and a "black box" warning — its strongest warning. Subsequently, Genentech Incorporated, Raptiva's manufacturer, issued a voluntary recall.

Plaque Psoriasis

Plaque psoriasis is the most common form of psoriasis, a chronic disease that causes skin cells to rapidly accumulate on the surface of the skin. While no cure exists, many patients are able to successfully manage their symptoms with cortisone creams, limited exposure to sunlight, and oral treatments such as Raptiva.

Many believe the company failed to properly warn consumers of the potentially fatal side effects of Raptiva. Others believe Genentech did not thoroughly test the medication before its release. In either instance, Genentech may be held liable for the harm Raptiva has done to consumers. Defective drug manufacturers are held to pharmaceutical and strict product liability laws that hold them responsible for any treatment defects their products cause.

When You Might Need an Attorney

If your life has been jeopardized due to the life-threatening side effects of Raptiva, contact a personal injury attorney with experience trying defective drug cases. A defective drug lawyer can arrange for expert testimony and any other elements needed to help you build a strong case against the manufacturer. Attorneys sometimes recommend victims join a class action lawsuit, because this type of lawsuit often leads to multi-million-dollar settlements for victims with similar cases. To learn more, contact a defective drug attorney today to determine if you need to file a Raptiva lawsuit.

Did You Know?

The FDA discourages patients from receiving vaccinations while on Raptiva, as the medication may interfere with the vaccination's mechanism of action, rendering it ineffective.